There are 3 bits to this post - an interview with Joan-Ramon Laporte. An article by Ariane Denoyel and a Q and A with Laporte and Healy. Laporte Interview As part of a series for ROAR Magazine, Frank Barat has run some striking interviews about aspects of the Covid pandemic not usually mentioned. Here is Joan-Ramon Laporte talking about the market in … [Read more...] about Covid and the Market in Research
Polypharmacy
Medications compromising Covid Infections
IN THE MIDST OF THE SARS-CoV-2 PANDEMIA, CAUTION IS NEEDED WITH COMMONLY USED DRUGS THAT INCREASE THE RISK OF PNEUMONIA. Joan-Ramon Laporte, M.D. Emeritus Professor of Clinical Pharmacology, Department of Pharmacology, Therapeutics and Toxicology Universitat Autònoma de Barcelona. Fundació Institut Català de Farmacologia. WHO Collaborating Centre for Research and Training … [Read more...] about Medications compromising Covid Infections
Polypharmacy: When is enough, enough?
Could you be on too many drugs? by Dr. Derelie (Dee) Mangin David Braley and Nancy Gordon Chair in Family Medicine, McMaster University The scenario is familiar: you or your mother or father has multiple pills to take at multiple times of the day. A pillbox called a dosette may be used to try and reduce the confusion and keep things on track. Where’s the problem? Surely … [Read more...] about Polypharmacy: When is enough, enough?